It is well established that surviving human adrenal slices 1) release corticosteroids into the media; 2) increase their output in response to ACTH, and 3) convert radioactive precursors to biologically active corticosteroids (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . In contrast, in vitro human adult androgen (C-19) production has not been well studied. Lombardo and Hudson (7) and Cooper and associates (3) isolated 11,/3-hydroxyandrostenedionel from the media after incubation of adrenal tissue from patients with metastatic breast carcinoma, prostatic carcinoma, and hypertension. Other C-19 steroids such as androstenedione or dehydroepiandrosterone were not identified by these workers," although these steroids and 11,8-hydroxyandrostenedione have been demonstrated in human adrenal vein blood (14) (15) (16) (17) . The adrenal origin of the aforementioned androgens is well documented by 17-ketosteroid secretory rate studies measured by isotope dilution (18, 19) .
Furthermore, pathways of adrenal androgen bio-* Supported by grants no. 254 (C-8 and C-9), C-3998, and A-4783 from the U. S. Public Health Service.
androsterone after extraction (without incubation) of a virilizing adrenal tumor removed from a 62-year-old woman (12) . In addition, Anliker, Rohr, and Marti isolated testosterone from a virilizing adrenal tumor (13) . synthesis in adult human tissues are also not well defined. Alternative pathways, two of which bypass progesterone have been postulated (20, 21) and are shown in Figure 1 . Reactions 2 and 4 requiring a 3,j-ol dehydrogenase and double-bond shift and reactions 1 and 3 requiring a 17a-hydroxylase are well recognized intermediate steps for mammalian and human corticosteroid biosynthesis. In 1957, Bloch, Dorfman, and Pincus reported the conversion of acetate-C14 to C14-labeled dehydroepiandrosterone, androstenedione, and 11,8-hydroxyandrostenedione by adrenal slices from a 28-year-old female with androgenital syndrome (22) . Recently, Goldstein, Gut, and Dorfman (23) and Lipsett and H6kfelt (24) demonstrated dehydroepiandrosterone synthesis with adult human adrenal homogenates and slices respectively via reactions 1 and 5 (pregnenolone 17a-hydroxypregnenolone -> dehydroepiandrosterone). Other alternative pathways of androgen biosynthesis were not described in these studies.
However, Solomon, Lanman, Lind, and Lieberman (25) incubated human fetal adrenal homogenates with progesterone-4-C14 and observed 17-hydroxylation and side-chain cleavage (reactions 3 and 7, Figure 1 ) with the formation of androstenedione. The biosynthetic capacity of fetal adrenal slices incubated with sodium-C14 acetate was verified further by Bloch and Benirschke (26) who isolated C-21 intermediates pregnenolone and 17a-hydroxyprogesterone and C-19 steroids-dehydroepiandrosterone, androstenedione, and 1 1,8- hydroxyandrostenedione.
Since androgen production and biosynthetic pathways were not completely resolved in adult adrenal tissue, an investigation was undertaken to study these aspects of C-19 metabolism with "normal," atrophic, "hypertensive," hyperplastic, adenomatous adrenal gland slices. Adrenal carcinomatous tissues from two children were investigated. This paper is a report of 1) isolation, measurement, and identification of adrenal androgens released into the incubation media with slices alone and with the addition of radioactive steroid precursors and 2) the in vitro effect of ACTH on androgen release and substrate conversion. Studies of corticosteroid production and biosynthesis by some of these tissue slices were reported previously ( 11, 27 (31) . The clinical impression of adrenal virilism (patients E.S. and C.S.) was corroborated by normal endogenous cortisol secretion (32) and studies of corticosteroid metabolism (27, 29) . Urinary 17-ketosteroids were elevated, predominantly of the 11-deoxy-17-ketosteroid fractions, dehydroepiandrosterone and etiocholanolone. Adrenal cortical suppression tests were not performed. 3 The patients (except L.J., whose small right adrenal gland was not removed) underwent total bilateral adrenalectomies at a one-stage operation (28) jumole, were added to some media prior to extraction (with the exception of the radioactive conversion studies). Constant specific activities of the free C-19 tracers were observed after reverse isotope dilution with paper chromatography.
The pooled washings and media were extracted twice with 3 volumes of dichloromethane which had been purified by passage through a silica-gel column. The dichloromethane extract was washed once with 1/10 volume of 0.05 N sodium hydroxide and twice with 1/10 volume of distilled water. The water was removed with anhydrous sodium sulfate and the extract evaporated in 5 The tritium-labeled steroids were purchased from the New England Nuclear Corp., Boston, Mass. Progesterone-4-C1" was generously donated by the Endocrine Study Section, National Institute of Health, Bethesda, Md. 6 Dr. H. Leon Bradlow, Sloan-Kettering Institute, New York, N. Y. graciously made this isotope available.
vOacto at 370 C. The residues were applied to washed M\hatmian no. 1 filter paper and developed for 72 hours in a modification of the toluene: propylene glycol system (38) .7 The effluents were collected and chromatographed for 20 hours in the cyclohexane: dioxane: methanol: water system (100: 100: 50: 25) which separated corticosteroids (corticosterone and 11-deoxycortisol) (34) from androgens. Dehydroepiandrosterone and androstenedione ran off the paper and were collected. On occasion the more polar C-19 steroids were located at the bottom of the paper. The effluents and paper eluates 8 were dried in vacuo and transferred quantitatively with chloroform to washed WN hatman no. 1 filter paper (28 x 1 inch strips with a common origin) in the heptane: 96 per cent methanol (1: 1) system of Bush and Willoughby. Fifteen to twenty Ag each of reference compounds, dehydroepiandrosterone, androstenedione, 118-hydroxyandrostenedione, and adrenosterone were applied together in a single spot on each side of the "extract area." The paper was equilibrated for 4 hours and the mobile phase allowed to develop for 14 to 16 hours,9 after which the paper was air dried. The C-19 steroids with a A-3-ketone configuration were located on the chromatograms by the ultraviolet scanning technique and the A5-3,8-ol steroid (dehydroepiandrosterone standard) by Zimmermann reagent stain (alkaline inz-dinitrobenzene). Appropriate areas corresponding to the standards and paper blanks were cut out and eluted with 4.0 ml of absolute ethanol as previously described (36) .
Measurements of the isolated androgens with a 5-3-ketone configuration were performed on portions of the eluates by the alkaline fluorescent method of Abelson and Bondy (39) . Authentic androstenedione was used in construction of the standard curve. The C-19 steroids were determined also by absorbance (0.8 ml microcuvets with a 1.0 cm light path) at 240 m~u (ethanol) in a Beckman model DU spectrophotometer. The extinction coefficients at 240 mA were used for the chemical determination. Dehydroepiandrosterone was converted to the 2,4-dinitrophenylhydrazone derivative and measured spectrophotometrically at 368 mA (36) .
A 0.5 ml portion of the ethanol eluate was counted to a standard error of + 2 per cent in a liquid phosphor scintillation counter (Model LP-2, Technical Measurements Corp., BNew Haven, Conn.), which had a counting efficiency of 45 to 48 per cent for carbon-14. The tritiumlabeled dehydroepiandrosterone 2,4-dinitrophenylhydrazone was plated at infinite thinness on aluminum planchets and counted to a ± 2 per cent standard error in a windowless gas-flow counter (Automatic Sample Changer, 8 Radioactive C-19 tracers were added at this stage of the steroid isolation if omitted previously, in order to correct for losses in purification. 9 Paper chromatography of the 17-ketosteroids was carried out in a room maintained at a constant temperature of 200 C and relative humidity of less than 50 per cent.
Model C110 B, Nuclear-Chicago Corp., Des Plaines, Ill.). The efficiency for tritium wlvas 18 to 20 per cent.
The final value was determined, taking into account the absorbance of the blank, chemical amount of the added carbon-14 tracer (0.20 /Ag or less), dilution factor, and the isotope recovery (40) . Since the chemical amount of the added dehydroepiandrosterone tracer was less than 0.01 lug, the steroid was calculated as the free compound without chemical correction. The calculation of the androgens isolated from media of the radioactive conversion experiments was uncorrected for isotope recovery, although other results were so corrected.
Identtification. The isolated androgens from the incubations without added radioactive substrates were pooled separately. The identification of A'-3-keto C-19 steroids was substantiated by characteristic mobilities and constant specific activities in two additional paper chromatographic systems, heptane: propylene glycol (41) and ligroin: benzene: methanol: water (667: 333: 800: 200) (42) . Areas of ultraviolet absorption and Zimmermann positive staining coincided with the radioactive peaks located by a gas-flow paper chromatogram scanner (Model C-100 B, Actigraph II, Nuclear-Chicago Corp., Des Plaines, Ill.). Androstenedione-C" and 11,8-hydroxyandrostenedione-C4 bis-2,4-dinitrophenylhydrazoines were formed (prior acetylation was unsuccessful) and confirmed by characteristic absorption maxima of 378 to 380 m/A (22) in the Beckman DU spectrophotometer. The specific activities of the hydrazones were determined by absorbance at 378 mu and calculated for the free compound. Radioactivity was measured by counting at infinite thinness on aluminum planchets to a standard error of + 2 per cent in the Nuclear-Chicago, Model C-110 B micro-window gas-flow counter. The efficiency for C1' was 24 to 28 per cent by this technique.
Dehydroepiandrosterone was verified as the mono-2, 4-dinitrophenylhydrazone derivative by the following criteria: 1) absorption maximum of 368 mu (chloroform); 2) characteristic position of only one radioactive peak on elution from micro-alumina columns (36) ; and 3) mnobility of the mono-2,4-dinitrophenylhydrazone (1 cm per hour) developed for 12 hours in the heptane: propylene glycol system (22) . The appropriate yellow radioactive area and paper blanks were cut into thirds, eluted with chloroform, and specific activities determined by spectrophotometry and windowless planchet counting with the Nuclear-Chicago Model C-110 B gas-flow counter. The specific activities were calculated on the basis of free dehydroepiandrosterone.
Radioactive androgens from the precursor experiments were identified after paper chromatographic separation and spectrophotometric and isotope measurements. One hundred micrograms of carrier androstenedione, ll3-hydroxyandrostenedione, and dehydroepiandrosterone were added to pooled paper eluates from experiments with a common radioactive substrate. The separate eluates were dried in vacuto at 370 C and the dried residues of each A'-3-ketone androgen product subj ected to a 40-tube countercurrent distribution (E-C Apparatus Company, H.) , hyperplastic (P.P.), and carcinomatous tissues (C.S.). The addition of ACTH to the system did not stimulate dehydroepiandrosterone production consistently. However, ACTH stimulated the carcinomatous tissues (C.S. and E.S.) to produce amounts of dehydroepiandrosterone in the range of the atrophic tissues of L.J. and AI.C. (Table  II) .
On the other hand, incubation of "Cushing adrenal tissue" (Table III) in the presence of ACTH resulted in a one and a half to sixfold increment of 11,8-hydroxyandrostenedione production. Nevertheless, the most exaggerated 11fl-hydroxyandrostenedione response to ACTH is found in the atrophic tissues (Table II) , associated clinically with adenomata.
The effect of ACTH on androstenedione release t Ratio SA is the ratio of the specific activity of the product to the specific activity of the substrate. the remainder of the eluates (from the 96 per cent methanol: heptane system) were pooled and specific activities determined. Radiochemical homogeneity of the isolated androgens is demonstrated by the data in Table V. B. Radioactive precursor conversion studies In Table VI are listed the data from the incubation of "normal" and pathological adrenal slices with progesterone-16-H3. Radioactive androstenedione and 11,8f-hydroxyandrostenedione were isolated from the media. The percentage conversion of progesterone to 11,8-hydroxyandrostenedione was higher than the percentage conversion of this precursor into androstenedione. The data demonstrate that less than one per cent (uncorrected for manipulative losses) of progesterone-16-H3 was converted to the C-19 steroids measured.
The "normal," hyperplastic, and adenomatous tissues released approximately the same amount of androgen in the presence of progesterone compared to similar incubations without this substrate (Tables II, III) . In contrast, incubation of 17a-hydroxypregnenolone-7a-H3 with adenomatous and hyperplastic slices resulted in conversion of 6 and 7 per cent of the substrate to androstenedione and 11,8-hydroxyandrostenedione, respectively (Table   VII ). In addition, 1.6 and 1.4 per cent of this substrate was converted to tritium-labeled dehydroepiandrosterone. There was a slight decrease in the specific activity (SA) between dehydroepiandrosterone, androstenedione, and 11,1/-hydroxyandrostenedione with the adenomatous slices of M.C. On the other hand, the SA of the androgens synthesized by the hyperplastic slices of P.P. are of the same order of magnitude, 14.3, 12.5, and 13.0 ,uc per Mmole (Table VII) .
Since these experiments suggested that 17a-hydroxypregnenolone alone appeared to be a better substrate than progesterone for adult adrenal androgen biosynthesis, an incubation of hyperplastic adrenal slices was carried out with a mixture of tritium-labeled 17a-hydroxypregnenolone and CA4-labeled progesterone. Ten units of ACTH per gram of slices was added to alternate flasks. In Table VIII the results of this study are listed. The percentage conversion of tritium-labeled 17a-hydroxypregnenolone to androstenedione and 11,8-hydroxyandrostenedione greatly exceeded that of C14-labeled progesterone. The percentage conversion of the 17a-hydroxypregnenolone to dehydroepiandrosterone was about the same (2.1) as the values observed in previous incubations with 17a-hydroxypregnenolone, 1.6 and 1.4 per cent (Table  VII) .
The low percentage conversion of 1 7a-hydroxypregnenolone to dehydroepiandrosterone compared to androstenedione and 11,8-hydroxyandrostenedione (Tables VII and VIII) Table   IX .
Identification of adrenal androgens from incubations with radioactive substrates. After chemical determinations were performed, the C-19 steroids derived from a common precursor were pooled separately and carrier androstenedione, 11,3-hydroxyandrostenedione, and dehydroepiandrosterone were added. (Carrier dehydroepiandrosterone was not added to paper eluates from the incuba- :L tion experiments with progesterone-H3) .1 Identification was verified by identical observed and theoretical distributions of the free androgens in the countercurrent systems and characteristic mobilities in two different paper chromatographic systems. The reported column (dehydroepiandrosterone only) and paper chromatographic mobilities and spectrophotometric spectra of the steroid 2,4-dinitrophenylhydrazone derivatives were observed, further substantiating the identification of the isolated androgens. The SA of the pooled androgens (and carriers) from individual substrate experiments (Tables VI-IX) along with the experimental conditions used, for identification are listed in Table X . Constant SA were maintained, indicating radiochemical purity of the measured compounds.
DISCUSSION
Androgen release by adult human adrenal gland slices. The use of an in vitro incubation technique with human adrenal slices affords a direct approach to an understanding of adrenal androgen metabolism. The data from the present incubations (Tables II-IV) indicate that the slices 1) release detectable amounts of free androgens, dehydroepiandrosterone, androstenedione, and 11,1-hydroxyandrostenedione into the media and 2) respond to adrenocorticotropin (ACTH) in vitro.
In the present study the amounts of dehydroepiandrosterone and androstenedione released per gland per three hours in vitro are less than the quantities found by Hirschmann, deCourcy, Levy, and Miller (17) in the adrenal vein blood of two patients with breast carcinoma and one patient with essential hypertension. In contrast, the adrenal venous blood levels of 11,8-hydroxyandro- stenedione are of the same order of magnitude found by the in vitro tissue slice method (Table  II) . There is also a marked discrepancy between the low dehydroepiandrosterone levels determined by the in vitro technique (and analysis of adrenal vein blood) (17) compared to the normal in vivo secretory rates of this C-19 steroid (15 to 25 mg 11 In the 17a-hydroxypregnenolone-H' studies, 100 ,g of carrier testosterone was added to a portion of the overflow from the cyclohexane: dioxane: methanol: water system. After acetylation, the extract was chromatographed in the heptane: propylene glycol system. The isolated testosterone acetate was devoid of radioactivity.
per 24 hours) determined by Vande Wiele and Lieberman (18) . 12 On the other hand, the adrenal tissue from three patients with Cushing's syndrome, L.H., L.J., and M.C. (Table IV) released 11/,-hydroxyandrostenedione, only in the presence of ACTH, commensurate with normal secretory rates of 2.0 mg per 24 hours reported by Bradlow and Gallagher (19) . The comparison between the two methods is made on the assumption that the 3-hour in vitro release rate projected to 24 hours is constant over that interval. The data of Cooper and associates (3) substantiate the validity of this speculation for C-21 steroids and 11f-hydroxyandrostenedione.
The stimulatory effect of ACTH on 11f-hydroxyandrostenedione production in vitro (Table  III) is in agreement with the data of Dyrenfurth, Lucis, Beck, and Venning (6); Touchstone, Glazer, Cooper, and Roberts (46); and Cooper and associates (3), despite the differences of glandular weights and pathological findings of the adrenal tissues. The most striking increase of 11,18-hydroxyandrostenedione production occurred with ACTH in the atrophic glands of L.J. and M.C. (Table II) , resulting in 8-and 34-fold increases, respectively. The functional capacity of these two tissues is demonstrated also by the effect of ACTH on dehydroepiandrosterone and androstenedione production. There is a slight rise of the androstenedione level in both tissues. However, the elevated (control) dehydroepiandrosterone in J.C. fell with ACTH, 14. substrates to C-19 steroids with "normal," hyperplastic, and adenomatous tissue slices. The data from Tables VI to IX suggest the probable biosynthetic sequence of androgen production shown in Figure 2 . The biosynthesis of dehydroepiandrosterone from 17a-hydroxypregnenolone with adenomatous and hyperplastic adrenal slices (Table VII) confirms previous observations of Lipsett and Hokfelt (24) . Their results, however, seem to indicate that 17a-hydroxypregnenolone is not the important "intra-adrenal" precursor of dehydroepiandrosterone in the "normal" adrenal gland slice. The in vitro data in Table VII Figure 2 . Also, 17a-hydroxypregnenolone can be converted to androstenedione via dehydroepiandrosterone. Villee, Engel, Loring, and Villee observed that fresh human fetal adrenal tissues formed androstenedione from progesterone 4-C14 early in gesta-tion but not after 12 to 15 weeks gestational age (53) . These investigators suggested the 21-hydroxylation appeared to reach a maximum at 12 to 15 weeks gestation with concomitant diminished 17-hydroxylation and disappearance of androstenedione. These findings are opposite to those of Solomon, Lanman, Lind, and Lieberman, who described 17a-hydroxyprogesterone and androstenedione conversion from progesterone-4-C14 with frozen fetal adrenal tissues of 10 to 22 weeks gestation (25) . Differences in co-factor additions (Solomon added diphosphopyridine nucleotide and adenosine triphosphate and Villee, triphosphopyridine nucleotide and glucose 6-phosphate) and the status of the tissues may account for the differences of the results. Although 17a-hydroxyprogesterone is present in normal and hyperplastic adult adrenal tissues (7, 28) , the factors regulating subsequent 21-hydroxylation of 17a-hydroxyprogesterone to 11-deoxycortisol (Compound S) compared to side-chain cleavage to androstenedione may determine the predominant direction of the pathway. When a mixture of tritium-labeled 17a-hydroxypregnenolone and C14-labeled progesterone are incubated with hyperplastic adrenal slices of A.D. (Cushing's syndrome, Table VIII), the H3: C14 ratios of androstenedione (15.8: 1) compared to cortisol (1.3: 1) (28) are observed. The high H3: C14 in androstenedione, despite the fact that much less androstenedione was produced compared to cortisol, suggests that the major proportion of this androgen and 11,8-hydroxyandrostenedione are probably derived via a pathway which does not utilize progesterone, presumably by way of 17a-hydroxypregnenolone > DHEA * androstenedione -* 11,8-hydroxyandrostenedione.
However, further studies are necessary to determine the significance of 17a-hydroxyprogesterone as an intermediate for adrenal androgen biosynthesis.
In addition, the high H3: C14 ratio of 11/3-hydroxyandrostenedione (22: 1) compared to cortisol (28) implies that "intra-adrenal" side-chain cleavage of cortisol is an unlikely pathway for 11,8- hydroxyandrostenedione formation. The data indicate that 11-hydroxylation of androstenedione is the more plausible explanation for the biosynthesis of 11,1/-hydroxyandrostenedione in the tissues studied.
The results of substrate conversions with adrenal slice incubations must be interpreted with reservation. Tissue membrane permeability, availability of intracellular co-factors, endogenous pools of steroid intermediates and products, and enzymatic activity are limiting factors not controlled by the tissue slice method. Further studies are thus necessary with purified human adrenal enzyme preparations to elucidate the conditions which regulate the pathways of pregnenolone metabolism to the corticosteroids, or androgens, or both.
SUMMARY
These studies demonstrate that fresh human adult "normal," atrophic, "hypertensive," hyperplastic, adenomatous, and carcinomatous tissue slices release dehydroepiandrosterone, androstenedione, and 11,8-hydroxyandrostenedione into the media after three hours of incubation in KrebsRinger bicarbonate buffer, fortified with glucose. The addition of ACTH to the system increases 11,8-hydroxyandrostenedione release in all tissues.
ACTH did not stimulate dehydroepiandrosterone and androstenedione release.
In addition, data are presented for the pathwaxs of adrenal androgen synthesis in "normal," hyperplastic, and adenomatous tissues. The data suggest that adrenal androgens are converted predominantly from 17a-hydroxypregnenolone -> dehydroepiandrosterone --androstenedione -* 11,3-hydroxyandrostenedione rather than from progesterone -* androstenedione -* 11,8-hydroxyandrostenedione.
